Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results75% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (5)
P 2 (1)
P 3 (3)

Trial Status

Recruiting3
Completed3
Not Yet Recruiting1
Terminated1
Active Not Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (9)

Research Network

Activity Timeline